Open access
Open access
Powered by Google Translator Translator

Guidelines & Reports

Position Paper: Mental health-related risk factors and interventions in patients with heart failure.

9 Mar, 2022 | 08:49h | UTC

Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC) – European Journal of Preventive Cardiology

 

Commentary on Twitter

 

Recent updates to clinical practice guidelines for diabetes mellitus.

9 Mar, 2022 | 08:46h | UTC

Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus – Endocrinology and Metabolism

 

AHA Scientific Statement: Cardio-oncology drug interactions.

8 Mar, 2022 | 09:53h | UTC

Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association – Circulation

 

Guideline: Diagnosis and therapy of vitiligo.

8 Mar, 2022 | 08:46h | UTC

S1 Guideline: Diagnosis and therapy of vitiligo – Journal of the German Society of Dermatology

 

CDC, AAP update developmental milestones for surveillance program.

8 Mar, 2022 | 08:47h | UTC

News Release: CDC, AAP update developmental milestones for surveillance program – AAP News

See Guidance: Evidence-Informed Milestones for Developmental Surveillance Tools – Pediatrics

Commentaries:

Revised Developmental Milestone Guidelines For Infants And Toddlers: Explained Here – Forbes

Much Awaited – Development Milestone Checklists Updated by CDC & AAP – Pediatric OnCall

 

Guidelines on management of persons with multimorbidity and polypharmacy.

8 Mar, 2022 | 08:41h | UTC

Italian guidelines on management of persons with multimorbidity and polypharmacy – Aging Clinical and Experimental Research

 

Guideline for perioperative management of patients with inflammatory rheumatic diseases.

8 Mar, 2022 | 08:43h | UTC

Perioperative management of patients with inflammatory rheumatic diseases – Zeitschrift für Rheumatologie

 

Over 1 billion people projected to live with obesity by 2030, warns new World Obesity Atlas.

7 Mar, 2022 | 00:12h | UTC

Commentary: Over 1 Billion People Projected to Live with Obesity by 2030, Warns New World Obesity Atlas – Health Policy Watch

Report: Obesity Atlas 2022 – Global Obesity Observatory

 

WHO global standard for safe listening venues and events.

7 Mar, 2022 | 00:17h | UTC

WHO global standard for safe listening venues and events – World Health Organization

Q&A: Deafness and hearing loss: Safe listening – World Health Organization

Commentaries:

WHO Releases New Noise Standard for Public Venues to Tackle Hearing Loss – Health Polity Watch

Obesity rates likely to double by 2030 with highest rises in lower-income countries – The Guardian

 

Commentary on Twitter (thread – click for more)

 

WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections.

7 Mar, 2022 | 00:09h | UTC

WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections – World Journal of Emergency Surgery

 

WSES guidelines on blunt and penetrating bowel injury: diagnosis, investigations, and treatment.

7 Mar, 2022 | 00:11h | UTC

WSES guidelines on blunt and penetrating bowel injury: diagnosis, investigations, and treatment – World Journal of Emergency Surgery

 

Updated WHO guidance conditionally recommends Molnupiravir for patients with non-severe covid-19 at highest risk of hospitalization.

4 Mar, 2022 | 09:57h | UTC

BMJ News Release: WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission – BMJ

WHO News Release: WHO updates its treatment guidelines to include molnupiravir

See updated guidance: A living WHO guideline on drugs for covid-19 – BMJ

Related:

Editorial (just published): Molnupiravir’s authorisation was premature – The BMJ

RCT: Molnupiravir reduced the risk of hospitalization or death in at-risk (i.e., obesity, over 60 years, etc.) unvaccinated adults with Covid-19.

Merck’s COVID pill loses its luster: what that means for the pandemic – “Molnupiravir was initially heralded by public-health officials as a game-changer for COVID-19, but full clinical-trial data showed lower-than-expected efficacy”.

FDA panel narrowly recommends authorization of first antiviral pill to treat COVID.

[Press release – not published yet] Merck’s new Covid-19 pill Molnupiravir updated data shows reduced efficacy (30%) for preventing hospitalization and death compared to initial results (50%). Absolute risk reduction of hospitalization and death fell from 7% to 3%.

8 lingering questions about the new Covid pills from Merck and Pfizer.

COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”.

[Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study.

A prominent virologist warns new COVID-19 pill could unleash dangerous mutants. Others see little cause for alarm.

The U.K. approves Merck’s COVID-19 antiviral pill, calling it a world first.

Merck to allow other nations to produce new COVID-19 antiviral.

Video: Merck’s Covid pill could transform treatment. Here’s how it works.

How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.

What we know — and don’t know — about Merck’s new Covid-19 pill.

[Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with mild or moderate COVID-19.

Merck’s Covid-19 pill is great news but may not be a game-changer.

Video | A Pill For COVID? A Doctor Explains Molnupiravir.

 

A guideline for the outpatient management of glycemic control in people with cancer.

4 Mar, 2022 | 08:56h | UTC

A guideline for the outpatient management of glycaemic control in people with cancer – Diabetic Medicine

 

ACR Guidelines for the Treatment of Juvenile Idiopathic Arthritis.

4 Mar, 2022 | 08:58h | UTC

News Release: The American College of Rheumatology releases two updated guidelines for treatment of juvenile idiopathic arthritis – American College of Rheumatology

 

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging – Arthritis & Rheumatology

 

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

 

AAP Clinical Report: Recognition and management of cardiovascular insufficiency in the very low birth weight newborn.

4 Mar, 2022 | 08:54h | UTC

Recognition and Management of Cardiovascular Insufficiency in the Very Low Birth Weight Newborn – Pediatrics

 

JCS/JHRS guideline focused update on non-pharmacotherapy of cardiac arrhythmias.

4 Mar, 2022 | 08:51h | UTC

JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias – Journal of Arrythmia

 

WHO: COVID-19 pandemic triggers a 25% increase in the prevalence of anxiety and depression worldwide.

3 Mar, 2022 | 09:44h | UTC

News Release: COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide – World Health Organization

Scientific Brief: Mental health and COVID-19: Early evidence of the pandemic’s impact – World Health Organization

 

Commentary on Twitter (thread – click for more)

 

Guideline: Management of Clostridioides difficile infection in hematopoietic cell transplant recipients.

3 Mar, 2022 | 08:17h | UTC

American Society for Transplantation and Cellular Therapy Series: #5 – Management of Clostridioides difficile infection in hematopoietic cell transplant recipients – Transplantation and Cellular Therapy

See other articles in the series:

American Society of Transplantation and Cellular Therapy Series, 1: Enterobacterales Infection Prevention and Management after Hematopoietic Cell Transplantation

 

American Society of Transplantation and Cellular Therapy Series, 2: Management and Prevention of Aspergillosis in Hematopoietic Cell Transplantation Recipients

 

American Society for Transplantation and Cellular Therapy Series: #3—Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation

 

American Society for Transplantation and Cellular Therapy Series: #4 – Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation

 

SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumors.

3 Mar, 2022 | 08:08h | UTC

SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021) – Clinical and Translational Oncology

 

SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients.

2 Mar, 2022 | 08:51h | UTC

SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients – Clinical and Translational Oncology

 

NICE Guideline: Mental wellbeing at work.

2 Mar, 2022 | 08:57h | UTC

Mental wellbeing at work – National Institute for Health and Care Excellence

 

Systematic Review: Postcholecystectomy diarrhea rate and predictive factors.

2 Mar, 2022 | 08:48h | UTC

Postcholecystectomy diarrhoea rate and predictive factors: a systematic review of the literature – BMJ Open

 

The management of diabetic ketoacidosis in adults—An updated guideline from the Joint British Diabetes Society for Inpatient Care.

1 Mar, 2022 | 09:00h | UTC

The management of diabetic ketoacidosis in adults—An updated guideline from the Joint British Diabetes Society for Inpatient Care

 

Guideline Update: Timing of elective surgery and risk assessment after SARS-CoV-2 infection – “The guidance remains that patients should avoid elective surgery within 7 weeks of infection, unless the benefits of doing so exceed the risk of waiting”.

1 Mar, 2022 | 08:58h | UTC

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia

Related:

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19

 

New CDC interim guidance recommends a 4-month Rifapentine-Moxifloxacin regimen to treat drug-susceptible pulmonary tuberculosis.

27 Feb, 2022 | 22:49h | UTC

Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022 – CDC Morbidity and Mortality Weekly Report

Related:

Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.

WHO Guideline: Screening for Tuberculosis Disease

New WHO Recommendations to Prevent Tuberculosis

CDC Guidelines for the Treatment of Latent Tuberculosis Infection

Guideline: Treatment of Drug-Resistant Tuberculosis

NICE Guideline: Tuberculosis

The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis

Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives

Guidelines for the Management of TB in Adults Living with HIV

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.